{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T21:09:54Z","timestamp":1771103394012,"version":"3.50.1"},"reference-count":46,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"15","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>von Hippel-Lindau disease\u2013associated hemangioblastomas (HBs) account for 20%\u201330% of all HB cases, with the appearance of new lesions often observed in the natural course of the disease. By comparison, the development of new lesions is rare in patients with sporadic HB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBSERVATIONS<\/jats:title>\n                    <jats:p>A 65-year-old man underwent clipping for an unruptured aneurysm of the anterior communicating artery. Fourteen years later, follow-up magnetic resonance imaging (MRI) revealed a strongly enhanced mass in the right cerebellar hemisphere, diagnosed as a sporadic HB. A retrospective review of MRI studies obtained over the follow-up period revealed the gradual development of peritumoral edema and vascularization before mass formation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LESSONS<\/jats:title>\n                    <jats:p>Newly appearing high-intensity T2 lesions in the cerebellum may represent a preliminary stage of tumorigenesis. Careful monitoring of these patients would be indicated, which could provide options for early treatment to improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/case23757","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T14:52:03Z","timestamp":1712587923000},"source":"Crossref","is-referenced-by-count":1,"title":["Time course of tumorigenesis of a newly developed sporadic hemangioblastoma in an elderly patient: illustrative case"],"prefix":"10.3171","volume":"7","author":[{"given":"Yu","family":"Sugiyama","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichiro","family":"Kuramitsu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Matsuno","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Suzaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Maesawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"1","key":"b1","series-title":"J Neurosurg","first-page":"24","article-title":"Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome","volume":"70","author":"Neumann HP","year":"1989","unstructured":"Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg. 1989;70(1):24\u201330."},{"key":"b2","series-title":"Front Oncol","first-page":"570103","article-title":"Incidence, prognostic factors and survival for hemangioblastoma of the central nervous system: analysis based on the surveillance, epidemiology, and end results database","volume":"10","author":"Yin X","year":"2020","unstructured":"Yin X, Duan H, Yi Z, Li C, Lu R, Li L Incidence, prognostic factors and survival for hemangioblastoma of the central nervous system: analysis based on the surveillance, epidemiology, and end results database. Front Oncol. 2020;10:570103."},{"issue":"5","key":"b3","series-title":"J Neurosurg","first-page":"1055","article-title":"Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease","volume":"120","author":"Lonser RR","year":"2014","unstructured":"Lonser RR, Butman JA, Huntoon K,  Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2014;120(5):1055\u20131062."},{"issue":"1","key":"b4","series-title":"Genet Med","first-page":"89","article-title":"Risk of new tumors in von Hippel-Lindau patients depends on age and genotype","volume":"18","author":"Binderup ML","year":"2016","unstructured":"Binderup ML, Budtz-J\u00f8rgensen E, Bisgaard ML Risk of new tumors in von Hippel-Lindau patients depends on age and genotype. Genet Med. 2016;18(1):89\u201397."},{"issue":"8","key":"b5","series-title":"Cancer Res","first-page":"4167","article-title":"Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell","volume":"66","author":"Gl\u00e4sker S","year":"2006","unstructured":"Gl\u00e4sker S, Li J, Xia JB,  Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell. Cancer Res. 2006;66(8):4167\u20134172."},{"issue":"2","key":"b6","series-title":"PLoS Med","first-page":"e60","article-title":"von Hippel-Lindau disease- associated hemangioblastomas are derived from embryologic multipotent cells","volume":"4","author":"Park DM","year":"2007","unstructured":"Park DM, Zhuang Z, Chen L,  von Hippel-Lindau disease- associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med. 2007;4(2):e60."},{"issue":"1","key":"b7","series-title":"Carcinogenesis","first-page":"102","article-title":"Hemangioblastomas might derive from neoplastic transformation of neural stem cells\/progenitors in the specific niche","volume":"32","author":"Ma D","year":"2011","unstructured":"Ma D, Zhang M, Chen L,  Hemangioblastomas might derive from neoplastic transformation of neural stem cells\/progenitors in the specific niche. Carcinogenesis. 2011;32(1):102\u2013109."},{"issue":"11","key":"b8","series-title":"J Neuropathol Exp Neurol","first-page":"885","article-title":"Developmentally arrested basket\/stellate cells in postnatal human brain as potential tumor cells of origin for cerebellar hemangioblastoma in von Hippel-Lindau patients","volume":"81","author":"Shively SB","year":"2022","unstructured":"Shively SB, Edwards NA, MacDonald TJ,  Developmentally arrested basket\/stellate cells in postnatal human brain as potential tumor cells of origin for cerebellar hemangioblastoma in von Hippel-Lindau patients. J Neuropathol Exp Neurol. 2022;81(11):885\u2013899."},{"issue":"5","key":"b9","series-title":"J Neurol Neurosurg Psychiatry","first-page":"644","article-title":"Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system","volume":"70","author":"Gl\u00e4sker S","year":"2001","unstructured":"Gl\u00e4sker S, Bender BU, Apel TW,  Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry. 2001;70(5):644\u2013648."},{"issue":"9","key":"b10","series-title":"Neuro Oncol","first-page":"1228","article-title":"Differences in genetic and epigenetic alterations between von Hippel-Lindau disease- related and sporadic hemangioblastomas of the central nervous system","volume":"19","author":"Takayanagi S","year":"2017","unstructured":"Takayanagi S, Mukasa A, Tanaka S,  Differences in genetic and epigenetic alterations between von Hippel-Lindau disease- related and sporadic hemangioblastomas of the central nervous system. Neuro Oncol. 2017;19(9):1228\u20131236."},{"key":"b11","series-title":"Acta Neuropathol Commun","first-page":"167","article-title":"Sporadic hemangioblastomas are characterized by cryptic VHL inactivation","volume":"2","author":"Shankar GM","year":"2014","unstructured":"Shankar GM, Taylor-Weiner A, Lelic N,  Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathol Commun. 2014;2:167."},{"issue":"4","key":"b12","series-title":"Trends Mol Med","first-page":"S62","article-title":"HIF-1 and tumor progression: pathophysiology and therapeutics","volume":"8","author":"Semenza GL","year":"2002","unstructured":"Semenza GL HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002;8(4 suppl):S62\u2013S67."},{"issue":"4","key":"b13","series-title":"Cell Metab","first-page":"524","article-title":"The role of HIF in immunity and inflammation","volume":"32","author":"McGettrick AF","year":"2020","unstructured":"McGettrick AF, O\u2019Neill LAJ The role of HIF in immunity and inflammation. Cell Metab. 2020;32(4):524\u2013536."},{"issue":"6","key":"b14","series-title":"J Anat","first-page":"639","article-title":"Blood-brain barrier breakdown in septic encephalopathy and brain tumours","volume":"200","author":"Davies DC","year":"2002","unstructured":"Davies DC Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat. 2002;200(6):639\u2013646."},{"issue":"33","key":"b15","series-title":"J Biol Chem","first-page":"23463","article-title":"Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors","volume":"274","author":"Antonetti DA","year":"1999","unstructured":"Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem. 1999;274(33):23463\u201323467."},{"issue":"31","key":"b16","series-title":"J Biol Chem","first-page":"21036","article-title":"Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability","volume":"284","author":"Murakami T","year":"2009","unstructured":"Murakami T, Felinski EA, Antonetti DA Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem. 2009;284(31):21036\u201321046."},{"key":"b17","series-title":"Front Cell Neurosci","first-page":"922181","article-title":"Blood-brain barrier alterations and edema formation in different brain mass lesions","volume":"16","author":"Solar P","year":"2022","unstructured":"Solar P, Hendrych M, Barak M, Valekova H, Hermanova M, Jancalek R Blood-brain barrier alterations and edema formation in different brain mass lesions. Front Cell Neurosci. 2022;16:922181."},{"issue":"6","key":"b18","series-title":"J Neurosurg","first-page":"1469","article-title":"Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study","volume":"122","author":"Kano H","year":"2015","unstructured":"Kano H, Shuto T, Iwai Y,  Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study. J Neurosurg. 2015;122(6):1469\u20131478."},{"issue":"1","key":"b19","series-title":"Neuro Oncol","first-page":"80","article-title":"Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease","volume":"12","author":"Asthagiri AR","year":"2010","unstructured":"Asthagiri AR, Mehta GU, Zach L,  Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Neuro Oncol. 2010;12(1):80\u201386."},{"issue":"22","key":"b20","series-title":"N Engl J Med","first-page":"2036","article-title":"Belzutifan for renal cell carcinoma in von Hippel-Lindau disease","volume":"385","author":"Jonasch E","year":"2021","unstructured":"Jonasch E, Donskov F, Iliopoulos O,  Belzutifan for renal cell carcinoma in von Hippel-Lindau disease. N Engl J Med. 2021;385(22):2036\u20132046."},{"issue":"22","key":"b21","series-title":"Clin Cancer Res","first-page":"4843","article-title":"FDA approval summary: belzutifan for von Hippel-Lindau disease-associated tumors","volume":"28","author":"Fallah J","year":"2022","unstructured":"Fallah J, Brave MH, Weinstock C,  FDA approval summary: belzutifan for von Hippel-Lindau disease-associated tumors. Clin Cancer Res. 2022;28(22):4843\u20134848."},{"issue":"1","key":"b22","series-title":"J Neurooncol","first-page":"239","article-title":"Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience","volume":"164","author":"Neth BJ","year":"2023","unstructured":"Neth BJ, Webb MJ, White J, Uhm JH, Pichurin PN, Sener U Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience. J Neurooncol. 2023;164(1):239\u2013247."},{"key":"b23","series-title":"JCO Precis Oncol","first-page":"e2300066","article-title":"Fatal intracranial hemorrhage with belzutifan in von Hippel-Lindau disease-associated hemangioblastoma: A case report","volume":"7","author":"Saeed Z","year":"2023","unstructured":"Saeed Z, Tasleem A, Asthagiri A, Schiff D, Jo J Fatal intracranial hemorrhage with belzutifan in von Hippel-Lindau disease-associated hemangioblastoma: A case report. JCO Precis Oncol. 2023;7:e2300066."},{"issue":"1","key":"b1","series-title":"J Neurosurg","first-page":"24","article-title":"Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome","volume":"70","author":"Neumann HP","year":"1989","unstructured":"Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg. 1989;70(1):24\u201330."},{"key":"b2","series-title":"Front Oncol","first-page":"570103","article-title":"Incidence, prognostic factors and survival for hemangioblastoma of the central nervous system: analysis based on the surveillance, epidemiology, and end results database","volume":"10","author":"Yin X","year":"2020","unstructured":"Yin X, Duan H, Yi Z, Li C, Lu R, Li L Incidence, prognostic factors and survival for hemangioblastoma of the central nervous system: analysis based on the surveillance, epidemiology, and end results database. Front Oncol. 2020;10:570103."},{"issue":"5","key":"b3","series-title":"J Neurosurg","first-page":"1055","article-title":"Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease","volume":"120","author":"Lonser RR","year":"2014","unstructured":"Lonser RR, Butman JA, Huntoon K,  Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2014;120(5):1055\u20131062."},{"issue":"1","key":"b4","series-title":"Genet Med","first-page":"89","article-title":"Risk of new tumors in von Hippel-Lindau patients depends on age and genotype","volume":"18","author":"Binderup ML","year":"2016","unstructured":"Binderup ML, Budtz-J\u00f8rgensen E, Bisgaard ML Risk of new tumors in von Hippel-Lindau patients depends on age and genotype. Genet Med. 2016;18(1):89\u201397."},{"issue":"8","key":"b5","series-title":"Cancer Res","first-page":"4167","article-title":"Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell","volume":"66","author":"Gl\u00e4sker S","year":"2006","unstructured":"Gl\u00e4sker S, Li J, Xia JB,  Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell. Cancer Res. 2006;66(8):4167\u20134172."},{"issue":"2","key":"b6","series-title":"PLoS Med","first-page":"e60","article-title":"von Hippel-Lindau disease- associated hemangioblastomas are derived from embryologic multipotent cells","volume":"4","author":"Park DM","year":"2007","unstructured":"Park DM, Zhuang Z, Chen L,  von Hippel-Lindau disease- associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med. 2007;4(2):e60."},{"issue":"1","key":"b7","series-title":"Carcinogenesis","first-page":"102","article-title":"Hemangioblastomas might derive from neoplastic transformation of neural stem cells\/progenitors in the specific niche","volume":"32","author":"Ma D","year":"2011","unstructured":"Ma D, Zhang M, Chen L,  Hemangioblastomas might derive from neoplastic transformation of neural stem cells\/progenitors in the specific niche. Carcinogenesis. 2011;32(1):102\u2013109."},{"issue":"11","key":"b8","series-title":"J Neuropathol Exp Neurol","first-page":"885","article-title":"Developmentally arrested basket\/stellate cells in postnatal human brain as potential tumor cells of origin for cerebellar hemangioblastoma in von Hippel-Lindau patients","volume":"81","author":"Shively SB","year":"2022","unstructured":"Shively SB, Edwards NA, MacDonald TJ,  Developmentally arrested basket\/stellate cells in postnatal human brain as potential tumor cells of origin for cerebellar hemangioblastoma in von Hippel-Lindau patients. J Neuropathol Exp Neurol. 2022;81(11):885\u2013899."},{"issue":"5","key":"b9","series-title":"J Neurol Neurosurg Psychiatry","first-page":"644","article-title":"Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system","volume":"70","author":"Gl\u00e4sker S","year":"2001","unstructured":"Gl\u00e4sker S, Bender BU, Apel TW,  Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry. 2001;70(5):644\u2013648."},{"issue":"9","key":"b10","series-title":"Neuro Oncol","first-page":"1228","article-title":"Differences in genetic and epigenetic alterations between von Hippel-Lindau disease- related and sporadic hemangioblastomas of the central nervous system","volume":"19","author":"Takayanagi S","year":"2017","unstructured":"Takayanagi S, Mukasa A, Tanaka S,  Differences in genetic and epigenetic alterations between von Hippel-Lindau disease- related and sporadic hemangioblastomas of the central nervous system. Neuro Oncol. 2017;19(9):1228\u20131236."},{"key":"b11","series-title":"Acta Neuropathol Commun","first-page":"167","article-title":"Sporadic hemangioblastomas are characterized by cryptic VHL inactivation","volume":"2","author":"Shankar GM","year":"2014","unstructured":"Shankar GM, Taylor-Weiner A, Lelic N,  Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathol Commun. 2014;2:167."},{"issue":"4","key":"b12","series-title":"Trends Mol Med","first-page":"S62","article-title":"HIF-1 and tumor progression: pathophysiology and therapeutics","volume":"8","author":"Semenza GL","year":"2002","unstructured":"Semenza GL HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002;8(4 suppl):S62\u2013S67."},{"issue":"4","key":"b13","series-title":"Cell Metab","first-page":"524","article-title":"The role of HIF in immunity and inflammation","volume":"32","author":"McGettrick AF","year":"2020","unstructured":"McGettrick AF, O\u2019Neill LAJ The role of HIF in immunity and inflammation. Cell Metab. 2020;32(4):524\u2013536."},{"issue":"6","key":"b14","series-title":"J Anat","first-page":"639","article-title":"Blood-brain barrier breakdown in septic encephalopathy and brain tumours","volume":"200","author":"Davies DC","year":"2002","unstructured":"Davies DC Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat. 2002;200(6):639\u2013646."},{"issue":"33","key":"b15","series-title":"J Biol Chem","first-page":"23463","article-title":"Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors","volume":"274","author":"Antonetti DA","year":"1999","unstructured":"Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem. 1999;274(33):23463\u201323467."},{"issue":"31","key":"b16","series-title":"J Biol Chem","first-page":"21036","article-title":"Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability","volume":"284","author":"Murakami T","year":"2009","unstructured":"Murakami T, Felinski EA, Antonetti DA Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem. 2009;284(31):21036\u201321046."},{"key":"b17","series-title":"Front Cell Neurosci","first-page":"922181","article-title":"Blood-brain barrier alterations and edema formation in different brain mass lesions","volume":"16","author":"Solar P","year":"2022","unstructured":"Solar P, Hendrych M, Barak M, Valekova H, Hermanova M, Jancalek R Blood-brain barrier alterations and edema formation in different brain mass lesions. Front Cell Neurosci. 2022;16:922181."},{"issue":"6","key":"b18","series-title":"J Neurosurg","first-page":"1469","article-title":"Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study","volume":"122","author":"Kano H","year":"2015","unstructured":"Kano H, Shuto T, Iwai Y,  Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study. J Neurosurg. 2015;122(6):1469\u20131478."},{"issue":"1","key":"b19","series-title":"Neuro Oncol","first-page":"80","article-title":"Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease","volume":"12","author":"Asthagiri AR","year":"2010","unstructured":"Asthagiri AR, Mehta GU, Zach L,  Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Neuro Oncol. 2010;12(1):80\u201386."},{"issue":"22","key":"b20","series-title":"N Engl J Med","first-page":"2036","article-title":"Belzutifan for renal cell carcinoma in von Hippel-Lindau disease","volume":"385","author":"Jonasch E","year":"2021","unstructured":"Jonasch E, Donskov F, Iliopoulos O,  Belzutifan for renal cell carcinoma in von Hippel-Lindau disease. N Engl J Med. 2021;385(22):2036\u20132046."},{"issue":"22","key":"b21","series-title":"Clin Cancer Res","first-page":"4843","article-title":"FDA approval summary: belzutifan for von Hippel-Lindau disease-associated tumors","volume":"28","author":"Fallah J","year":"2022","unstructured":"Fallah J, Brave MH, Weinstock C,  FDA approval summary: belzutifan for von Hippel-Lindau disease-associated tumors. Clin Cancer Res. 2022;28(22):4843\u20134848."},{"issue":"1","key":"b22","series-title":"J Neurooncol","first-page":"239","article-title":"Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience","volume":"164","author":"Neth BJ","year":"2023","unstructured":"Neth BJ, Webb MJ, White J, Uhm JH, Pichurin PN, Sener U Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience. J Neurooncol. 2023;164(1):239\u2013247."},{"key":"b23","series-title":"JCO Precis Oncol","first-page":"e2300066","article-title":"Fatal intracranial hemorrhage with belzutifan in von Hippel-Lindau disease-associated hemangioblastoma: A case report","volume":"7","author":"Saeed Z","year":"2023","unstructured":"Saeed Z, Tasleem A, Asthagiri A, Schiff D, Jo J Fatal intracranial hemorrhage with belzutifan in von Hippel-Lindau disease-associated hemangioblastoma: A case report. JCO Precis Oncol. 2023;7:e2300066."}],"container-title":["Journal of Neurosurgery: Case Lessons"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/7\/15\/article-CASE23757.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/7\/15\/article-CASE23757.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/7\/15\/article-CASE23757.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:23:57Z","timestamp":1770301437000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/7\/15\/article-CASE23757.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":46,"journal-issue":{"issue":"15"},"URL":"https:\/\/doi.org\/10.3171\/case23757","relation":{},"ISSN":["2694-1902"],"issn-type":[{"value":"2694-1902","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]}}}